Sterilisation of forex flows is the set of monetary operations through which a central bank offsets the domestic liquidity created or destroyed when it intervenes in the foreign-exchange market. The legal and institutional basis in India rests with the Reserve Bank of India, which manages the external value of the rupee under the Reserve Bank of India Act, 1934, and operates within the managed-float regime that India adopted after the 1993 unification of the exchange rate following the 1991 balance-of-payments crisis. When the RBI buys foreign currency—typically US dollars—to prevent the rupee from appreciating during heavy capital inflows, it pays for those dollars by creating rupees, expanding base money. Sterilisation is the corrective leg of this operation: the central bank withdraws an equivalent quantum of rupee liquidity so that the intervention does not stoke domestic inflation or undermine the monetary-policy stance set by the Monetary Policy Committee constituted under the amended RBI Act of 2016.
The mechanics proceed in two linked steps. First, the intervention: faced with appreciation pressure, the RBI's Financial Markets Operations Department purchases dollars in the spot or forward market, adding the proceeds to its foreign-exchange reserves and injecting rupees into the banking system. Second, the sterilisation: to neutralise that injection, the RBI conducts an offsetting contraction, most commonly by selling government securities from its portfolio through open-market operations (OMOs). The sale absorbs the freshly created rupees, leaving the monetary base broadly unchanged while reserves rise. The reverse sequence applies during outflows—the RBI sells dollars, drains rupees, and then injects liquidity through OMO purchases or repo operations to prevent a credit squeeze. The defining feature is that the exchange-rate objective and the domestic-liquidity objective are decoupled and pursued with separate instruments.
Several instruments supplement plain-vanilla OMOs, because a finite stock of government bonds limits how much liquidity the RBI can absorb by selling securities. The Market Stabilisation Scheme (MSS), launched in April 2004 under a memorandum of understanding between the RBI and the Government of India, allows the issuance of dedicated treasury bills and dated securities whose proceeds are impounded in a separate, non-fungible MSS cash account and not spent by the government. The Cash Reserve Ratio can be raised to lock up bank reserves, as the RBI did during the 2007–08 surge in inflows. The Liquidity Adjustment Facility, the variable reverse-repo, and the Standing Deposit Facility introduced in April 2022 provide finer day-to-day absorption. Sterilisation may be full or partial; in practice the RBI often sterilises incompletely, tolerating some liquidity expansion to balance competing objectives.
Contemporary practice is visible in concrete episodes. During the post-2003 capital-inflow boom, the RBI under Governor Y. V. Reddy combined MSS issuance with CRR hikes, and outstanding MSS securities peaked near ₹1.7 lakh crore in early 2008 before being unwound when the global financial crisis reversed flows. The MSS was briefly revived in late 2016 to absorb the liquidity glut following demonetisation. Through 2020–2024, as reserves climbed past US$640 billion, the RBI relied chiefly on spot and forward-market intervention and graduated open-market and term operations rather than large MSS issuance. Other central banks face identical arithmetic: the People's Bank of China sterilised massive inflows in the 2000s through central-bank bills and reserve-requirement hikes, while the Swiss National Bank and Bank of Japan have conducted intervention with varying degrees of sterilisation.
Sterilisation must be distinguished from adjacent concepts. It is the opposite of unsterilised intervention, in which the central bank allows the forex purchase to expand the money supply, accepting the inflationary consequence in exchange for a stronger exchange-rate effect. It differs from capital controls, which restrict the flows at source rather than neutralise their monetary footprint after the fact. It is also distinct from the broader impossible trinity (or trilemma), which holds that a country cannot simultaneously maintain a fixed exchange rate, free capital movement, and an independent monetary policy; sterilisation is precisely the device by which a managed-float economy tries to soften that trilemma, buying partial monetary autonomy despite open capital accounts and a quasi-managed rate.
The practice carries well-documented costs and controversies. Sterilisation is quasi-fiscal: the RBI earns relatively low yields on its dollar-denominated reserve assets while paying higher domestic interest on the securities it sells or the MSS paper it issues, generating a negative carry borne ultimately by the public balance sheet. Persistent intervention has drawn external scrutiny—the United States Treasury placed India on its currency-manipulation monitoring list in successive semi-annual reports during 2018–2021 over reserve accumulation, though it stopped short of a manipulation designation. Domestically, heavy sterilised intervention can keep domestic yields elevated, crowd out private borrowing, and entrench expectations of one-sided RBI support. The finite-instruments problem means sustained, large-scale sterilisation is not indefinitely feasible.
For the working practitioner—whether a UPSC aspirant tackling GS Paper III, a markets desk officer, or a balance-of-payments analyst—sterilisation is the operational hinge linking external-sector management to domestic monetary policy. It explains why surging reserves need not translate into runaway inflation, why the RBI's liquidity operations spike during episodes of large foreign portfolio investment, and why exchange-rate and inflation outcomes can be managed semi-independently in an economy with open capital accounts. Mastery of the concept requires holding three things together: the intervention, its monetary footprint, and the offsetting instrument that erases it.
Example
In late 2016, the RBI revived the Market Stabilisation Scheme, issuing cash-management bills to sterilise the surge of bank liquidity that followed the November demonetisation announcement.
Frequently asked questions
Buying dollars creates rupees and expands base money, which can fuel inflation and loosen the monetary stance set by the MPC. Sterilisation withdraws that liquidity through offsetting operations, preserving the inflation-control objective while still building reserves.
Keep learning